Microsoft said it plans to invest $10 billion in Japan between 2026 and 2029 to build AI infrastructure.

Chinese chip companies have benefited from strong domestic demand for AI as U.S. tech curbs have bolstered local firms.

Analysts have said adoption of the $30-per-month Microsoft 365 Copilot is in the early stage.

Coinbase has received conditional approval from the U.S. Office of the Comptroller of the Currency (OCC) to operate as a trust bank, the company said Thursday.

OpenAI did not disclose the terms of the deal but said TBPN will be housed within its strategy organization.

With the war in Iran now in its fifth week, Amazon said it's adding a 3.5% fuel and logistics surcharge for third-party sellers in the U.S. and Canada.

The Trump administration is preparing to impose new tariffs on drugmakers that have not struck deals with the president to lower their U.S. drug prices.

While global uncertainty has weighed on deal count, family offices and corporate investors are still piling into megadeals.

Tesla is coming off a year of declining deliveries due in part to increased competition from rivals in China offering lower-cost models.

Blue Owl attributed the higher-than-usual requests to "heightened market concerns around AI-related disruption to software companies."

Here are five key things investors need to know to start the trading day.

Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.

These are the stocks posting the largest moves in the premarket.

Stellantis-backed Leapmotor delivered 110,155 new energy vehicles in the first three months of 2026, exceeding 100,000 deliveries for a fourth-straight quarter.

Various car selling platforms have reported a sharp increase in consumer interest for EVs since the Middle East crisis began.

A deal with Globalstar could bolster Amazon Leo, the company's nascent internet-from-space service, which has about 200 satellites in orbit.

Eli Lilly opposes the White House's push to codify "most favored nation" drug pricing into law, CEO Dave Ricks said in an interview with CNBC.

Franklin Templeton has agreed to buy 250 Digital, which will join the newly established unit Franklin Crypto, as the firm deepens its digital assets push.

Elon Musk's SpaceX is reportedly targeting a valuation of around $1.75 trillion in its forthcoming IPO.

These are the stocks posting the largest moves in midday trading.

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.

The semiconductor company will now wholly own Fab 34 after spending $14.2 billion to repurchase the 49% stake it sold to Apollo Global Management two years ago.

Oracle plans to cut thousands of jobs which will free up cash flow as the company aggressively invests in its AI data center buildout.

Here are five key things investors need to know to start the trading day.

Visa's new tools are part of a larger push by major banks and financial institutions to incorporate AI into their businesses.

As Apple turns 50, the iPhone maker faces questions about succession, its role in AI and whether it can maintain a premium brand.

These are the stocks posting the largest moves premarket.

Xpeng's deal to make software, hardware and even vehicles with VW Group in China shows that Chinese firms are now making the high-value components.

Sen. Warren said the Trump administration trade negotiations are focused on giving advantages to Trump's "tech billionaire friends."

Iran's Islamic Revolutionary Guard Corps (IRGC) has warned a number of tech companies with Middle East operations they'll be considered "legitimate targets."

Baidu's Apollo Go robotaxis stopped mid-traffic in a Chinese city on Tuesday, leading to at least one highway collision, according to social media.

Shares of Chinese AI company Zhipu surged over 30% in trading, after posting strong revenue growth in its first earnings report since its IPO.

See which stocks are posting big moves after the bell.

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

Mercedes is investing $4 billion in its Alabama plant through 2030 in a push to increase production as the automaker targets a 28% increase in U.S. car sales.

The Berkshire Hathaway chairman said the growing number of nuclear-armed states has fundamentally altered the global risk landscape.

Bank of America data reveals lower-income consumers are already pulling back on spending. Consumer sentiment shows higher earners are feeling less confident.

Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake.

Apple remains Berkshire Hathaway's largest holding even after the conglomerate trimmed its stake at the end of last year.

The 95-year-old investor said he still comes into the office daily and stays engaged with markets.

When including internal customers, the telecommunications giant said cloud computing revenue grew from a year ago.

The winning bidder — along with up to seven guests — will join Buffett and the Currys for an exclusive lunch in Omaha, Nebraska.

Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.

These are the stocks posting the largest moves premarket.

In the wake of the Iran war, prices are surging for critical elements used in defense and the semiconductors that power artificial intelligence advances.

A week of "maximum uncertainty" should deliver a key opportunity for investors, according to Evercore ISI's Julian Emanuel.

These are the stocks posting the largest moves in midday trading.

The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.

Merging the companies is an opportunity in fast-growing nutrition space, said Danone CEO Antoine de Saint-Affrique.

With rising inflation and changing tariff policies, menstrual products have seen a drastic rise in price over the past few years.

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses.

Two months after its launch, CNBC's rare disease initiative is starting to reach a broader audience.

The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.

Many Americans face financial pressures after Affordable Care Act enhanced premium subsidies expired at the end of 2025.

Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.

Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in patients with Type 2 diabetes.

Johnson & Johnson said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots.

"On balance, we do not like the risk/reward balance in Lilly shares," the analysts wrote.

Wiles "will be spending virtually full time at the White House" while being treated for breast cancer, President Donald Trump said Monday.